be independent from the role played by Cx40 in the regulation of blood pressure. 18 These studies that uncovered an unsuspected link between endothelial Cx40 expression and tumor angiogenesis point at Cx40 as a potential target for a new class of antiangiogenic therapies.
Here, we tested whether Cx40 regulates angiogenesis of nontransformed tissues. We used the angiogenesis model of the mouse retina in which vascularization occurs postnatally. By comparing wild-type (WT), Cx40 knockout (Cx40 −/− ), and Cx40 −/− ;Tie2 (tyrosine kinase receptor Tie2)-Cx40 mice in which Cx40 is restored in ECs, 19 we show that loss of endothelial Cx40 delays the development of retinal vessels by affecting their growth and maturation. Interfering with Cx40 expression or function in vitro and in vivo shows that endothelial Cx40 contributes to EC proliferation and to neovessel maturation, via a mechanism which may involve an increased secretion of PDGF species by ECs. Thus, endothelial Cx40 is required for proper developmental angiogenesis of the retina. The implication of Cx40 in retinal neovascularization identifies this protein as a novel therapeutic target in proliferative retinopathies.
Materials and Methods
Materials and Methods are available in the online-only Data Supplement.
Results

Loss of Endothelial Cx40 Delays the Vascularization of the Neonatal Retina
To explore the role of Cx40 in physiological angiogenesis, we used the mouse retina model in which vascularization occurs postnatally and in an orderly and stereotypical manner. Starting from the first postnatal day (P0), vascular sprouts emerge from the central vessels at the optic nerve head then grow following a VEGF gradient to form a primitive vascular plexus that extends 2 dimensionally across the superficial layer of the retinal surface, reaching the peripheral margin of the retina by P8. From P7 to P15, these superficial vessels form vertical sprouts that give rise to the deep vascular plexus, then the intermediate vascular plexus within the depth of the retina. 20 Analysis of flat-mounted retinas from WT mice at P6 revealed that Cx40 is expressed in CD31-positive ECs of the large and differentiated retinal vessels ( Figure 1A −/− than in control WT mice ( Figure 1E ). In contrast, the retinal vasculature of Cx40 −/− ;Tie2-Cx40 transgenic mice, that express Cx40 under the control of the endothelialspecific Tie2 promoter, 19 was indistinguishable from that of WT controls (Figure 1B through 1E ; Figures III and IV in the online-only Data Supplement). Together, the data show that loss of Cx40 reduces EC proliferation during vascularization of the primary retinal plexus and that restoring Cx40 expression in ECs is sufficient to restore a controlled angiogenesis in P6 Cx40
−/− mice. To determine whether Cx40 deficiency delays or decreases the vascularization of the developing retina, we examined the vascular network at P9, P15, and P28 (adult) stages. Analysis of flat-mounted retinas revealed that the superficial vascular plexus had already reached the retinal edges at P9 in WT, Cx40 −/− , and Cx40 −/− ;Tie2-Cx40 mice ( Figure 
Loss of Endothelial Cx40 Affects EC Growth and Mural Cell Recruitment at the Angiogenic Front
We then examined in further detail the angiogenesis defects that manifested at the sprouting area of the angiogenic front populated by tip cells known to have a minimal proliferative rate. 3 Higher magnifications of P6 Cx40 −/− retinas revealed a significant reduction in the number of vessel sprouts when compared with WT mice (Figure 2A ). We also addressed vessel maturation in retinas, using mural cell markers. neural/glial antigen 2-positive cells covered all vessels, and we did not observe any alteration in neural/glial antigen 2 staining in Cx40 −/− retinas ( Figure 2B ; Figure of αSMA (α-smooth muscle actin) staining, showing mural cell coating of the main vessels, were observed at low magnification ( Figure 2C ; Figure VIIIB in the online-only Data Supplement). However, at higher magnification, αSMA was also seen at the tips of the sprouts, likely reflecting the recruitment of mesenchymal precursors on newly formed endothelial tubes 21 ( Figure 2C ). At this location, the overall detection of αSMA, desmin, and PDGFRβ (β-type platelet-derived growth factor receptor) markers were significantly increased in Cx40 −/− mice over WT levels ( Figure 
Downregulation of Cx40 Signaling in Microvascular ECs Affects Their Proliferation and Their Ability to Chemoattract Mural Cells In Vitro
To explore the consequences of Cx40 alterations at the cell level, we used immortalized mouse brain endothelial cell line (bEnd.3) cells, an established model of murine microvascular ECs that display a Cx expression pattern similar to that of native microvascular ECs. 22 Transfection of bEnd.3 cells with siRNAs targeting Cx40 reduced the expression of this Cx by ≈90%, but not that of Cx37 or Cx43 ( Figure IXA and IXB in the online-only Data Supplement). The downregulation of Cx40 expression in confluent bEnd.3 cells markedly decreased their proliferation but had no effect when cells were seeded at low density, suggesting a role of Cx40-mediated intercellular communication in bEnd.3 cells proliferation ( Figure 3A) . Exposing bEnd.3 cells to the pan-Cx inhibitor carbenoxolone, or 300 µmol/L 40 Gap27, a peptide interfering with Cx40 gap junction specifically (mimetic of the Cx40 extracellular loop domain 23 ), but not its scrambled version, also decreased the proliferation rate of these cells ( Figure 3B 24, 25 across an artificial membrane. SMC chemomigration was markedly enhanced when Cx40 was silenced in bEnd.3 cells ( Figure 3C ). Similar observations were made when confluent, control, or Cx40-silenced ECs were replaced by their conditioned medium ( Figure 3D ). These data indicate that reducing Cx40 expression promotes the chemotactic recruitment of αSMA-and PDGFRβ-positive SMCs by ECs and that the effect is mainly driven by a soluble factor.
Loss of Cx40 Increases the Release of PDGF Isoforms by Microvascular ECs
To identify the signaling components linking Cx40 and vascular maturation, we compared the levels of angiogenesisrelated proteins released in the supernatants of Cx40-silenced and control bEnd.3 cell cultures using a mouse angiogenesis array. When Cx40 expression was silenced, the assay detected increased production of PDGF-AA, AB, and BB isoforms ( Figure 4A ). ELISA analysis of the cell-conditioned media confirmed the changes in PDGF-AB and -BB secreted levels ( Figure 4B ). However, Western blot analysis of PDGF-BB expression did not reveal any alteration between control and Cx40-depleted bEnd.3 cell extracts ( Figure 4C ), suggesting that Cx40 regulates the secretion of PDGF isoforms rather than their synthesis.
We then examined the contribution of the PDGF signaling in the bEnd.3 cell-induced transmigration of SMCs. In presence of blocking anti-PDGF-BB antibodies, the migration of SMCs induced by bEnd.3 cell-conditioned medium returned to basal levels (Figure X in the online-only Data Supplement). These data indicate that PDGF-BB is crucially involved in the bEnd.3 cell-induced transmigration of SMCs and that the increased release of PDGF isoforms detected in Cx40-depleted bEnd.3 cell extracts could account for the enhanced SMC recruitment observed under these conditions.
Targeting Cx40 Decreases Neoangiogenesis in the Mouse Retina
We next explored the consequences of inhibiting Cx40 functions during physiological retinal angiogenesis. Intraocular administration of 15 µg
40
Gap27 peptide in P5 WT pups resulted in a reduction of the vascular coverage and radial extension of retinal vessels in P6 pups, when compared with control (scramble peptide)-injected pups ( Figure 5A ). At the angiogenic front, capillary density, capillary branch points, and meshes were reduced in 40 Gap27-treated mice ( Figure 5B and 5C ). At the sprouting area of the angiogenic front, exposure to the 40 Gap27 peptide reduced sprout formation ( Figure 5D ), while increasing the abundance of the mural cell marker PDGFRβ around the newly formed EC tubes ( Figure 5E ). These data show that a peptide known to interfere with Cx40 functions mimics, in living WT mice, the vascular retinal phenotype of Cx40 −/− mice.
Discussion
Our findings provide the first insight that microvascular EC Cx40 regulates the development of the vasculature in the postnatal mouse retina. Using Cx40-null mice, 26 we show that loss of Cx40 reduces the development of retinal vessels in vivo, in association with reduced EC proliferation and sprouting activity at the vascular front, and increased detection of some mural cell markers along angiogenic sprouts. Selective reexpression of Cx40 in ECs 19, 27 corrects the Cx40-null phenotype, whereas administration of a Cx40 channel inhibitor for a single day in WT mice is sufficient to mimic the deficit of EC Cx40 during retinal angiogenesis.
The vascularization defects observed in Cx40-null mice are in line with previous reports describing the importance of Cx40 during the formation of new blood vessels in various in vivo and in vitro models. 18, [28] [29] [30] These defects are transient as they are no longer detected in P15 and adult mice. Such temporary alterations in postnatal retinal angiogenesis have been observed in various transgenic animals and could rely on the development of compensatory mechanisms that sometimes arise in knockout mice. 31, 32 Our in vivo experiments showing that EC proliferation is reduced on Cx40 genetic ablation are in agreement with those reporting, in vitro, the consequences on EC proliferation of the physiological downregulation of Cx40 expression by normal laminar shear stress. 33 The role of vascular Cxs on cell proliferation is complex, [34] [35] [36] and further studies will identify the nature of the Cx40 signals controlling EC proliferation and behavior during angiogenesis. It could be a diffusible mediator, a specific factor or an miRNA, exchanged through Cx40-containing gap junctions. 37 Our study highlights that loss of Cx40 expression has pleiotropic effects during retinal angiogenesis, affecting both neovessel growth and maturation. These defects may reflect an overall reduced sensitivity of Cx40-deprived ECs toward angiogenic stimuli. Alternatively, in vivo, the loss of Cx40 may affect the expression of others vascular Cxs 12,27,38 with consequences on the Ca 2+ responses spread between ECs and on their production of nitric oxide, 12,39 2 physiological processes that are essential for EC functions. 40, 41 Cx40 also contributes to the formation of myoendothelial gap junctions in arteries and arterioles by interacting with Cx43 and Cx45 expressed Gap27-injected mice when compared with control-injected mice. Scale bar=100 μm. Data are representative from 3 independent experiments, a total of (Continued ) by mural cells to form functional heterotypic channels. 42, 43 Although Cx40 seems faintly expressed at areas of endothelial and mural cell contacts in WT and Cx40 −/− ;Tie2-Cx40 P6 retinas, we cannot exclude that, in Cx40 −/− animals, the absence of Cx40 could affect the coupling between capillary ECs and mural cell precursors, leading to impaired neovessel formation and maturation.
Interestingly, our experiments show that reexpression of Cx40 under the Tie2 promoter corrects most of the alterations detected in Cx40 −/− animals. However, as the Tie2 promoter is active in bone marrow-derived endothelial precursor cells and a subpopulation of endothelial precursor cells expresses Cx40, [44] [45] [46] we cannot rule out a potential contribution of circulating Cx40-positive endothelial precursor cells to neonatal retinal angiogenesis 47 in our transgenic mice. We further detected increased staining for PDGFRβ, αSMA, and desmin mural cell markers along angiogenic sprouts in Cx40 −/− retinas, whereas neural/glial antigen 2 staining was unaltered. These observations suggest that Cx40 signaling controls the recruitment and differentiation of mural cell precursor subpopulations. Vascular maturation and more specifically mural cell precursor recruitment after vessel formation is a complex process that is mainly regulated by the PDGF-BB/PDGFRβ signaling. 48 PDGF-BB is a key molecule in pericyte chemotaxis that promotes endothelial/pericyte cellcell contact. Our data indicate that this molecule mediates the bEnd.3 cell-induced recruitment of SMCs. Moreover, the levels of PDGF isoforms detected in the supernatants collected from EC cultures were increased on Cx40 silencing, whereas no difference in PDGF synthesis could be detected in cell extracts. These results suggest that Cx40 modulates the migration of SMCs by regulating the secretion of PDGF by ECs. The hypothesis of a role of Cx40 in the control of PDGF secretion is supported by previous studies reporting the crucial role of various Cxs in the secretion of many products, under physiological and pathophysiological conditions. 49 The limited data available on PDGF secretion 50 indicate that PDGF isoforms are secreted in α-granules by a mechanism regulated by intracellular cAMP (cyclic adenosine monophosphate) and Ca 2+ concentrations. 51 The altered Ca 2+ signaling in ECs lacking Cx40 39 could account for the increased release of endothelial PDGF secretion. The expression of PDGF-BB has been shown to be the highest in tip cells, from which secretion is expected to establish a gradient allowing efficient pericyte recruitment. 5, 52, 53 A disruption of this gradient could disturb the process and delay vascular development in Cx40 −/− mice. We may thus speculate that the increased coverage of PDGFRβ-positive mural cells around the retinal neovessels in Cx40 −/− mice is a direct consequence of increased PDGF secretion. In this scenario, the production of PDGF is likely to be moderate as we did not observed the marked retinal disorganization reported in situations of PDGF-BB overproduction. 54, 55 Levels of Cx40 are altered in many human disease conditions, including hypertension, associated with various polymorphisms. 56 More recently, a reduction in Cx40 expression was shown to play a role in the development of the vascular defects of hereditary hemorrhagic telangiectasia. By highlighting the impact of Cx40 signaling on the development of a vascular network, this study already pointed at Cx40 as a potential therapeutic target for vascular diseases. 57 In our study, intraocular injections of the 40 Gap27 inhibitory peptide in mice for a short period of time proved to be effective locally, in reducing retinal angiogenesis. Thus, the effect of the Cx40 mimetic peptide is very similar to the effect achieved by silencing Cx40. Further studies will explore if similar mechanisms of action are involved in the 2 situations. The direction for applications of our findings should be the development of therapeutic approaches for eye diseases involving excessive angiogenesis and vascular abnormalities. 58 Although photocoagulation remains the standard treatment for diabetic retinopathy, intravitreal administrations of anti-VEGF agents are currently approved for the management of ocular neovascular diseases. 59, 60 These agents are recognized for their beneficial effects on visual acuities, 2 but some reoccurrences have been reported and a lack of data about the long-term side effects of these treatments is still missing. 59 Our data provide evidences that loss of Cx40 or administration of a mimetic peptide interferes with the mechanisms of vessel growth and maturation in conditions of stimulated angiogenesis. These results open the perspectives of further studies to determine the benefits of targeting Cx40 channels locally to treat retinopathy. Gap27-injected retinas were analyzed. C, The complexity of the network, assessed by the number of branch points and meshes, is also reduced in 40 Gap27-treated mice compared with control-injected mice. Scale bar=100 μm. Data are representative from 3 independent experiments, a total of n=6 control-injected and 6 40 Gap27-injected retinas were analyzed. D, The number of sprouts at the angiogenic front is reduced in the 40 Gap27-treated mice. Scale bar=100 μm. Data are representative from 3 independent experiments, a total of n=6 control-injected and 6 40 Gap27-injected retinas were analyzed. E, Dual labeling for IB4 (Isolectin B4; pink) and PDGFRβ (β-type platelet-derived growth factor receptor; green) showing increased surface areas covered by PDGFRβ-positive cells around newly formed vessels in WT mice injected with the 40 Gap27 peptide, compared with mice injected with the scramble peptide. Scale bar=20 μm. Data are representative from 3 independent experiments, a total of n=6 control-injected and 6 40 Gap27-injected retinas were analyzed. Data information: graphs from (A-E) are presented as means+SEM. *P<0.05; **P<0.01; ***P<0.001 vs scramble peptide.
